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Despite the widespread use of the cell-surface receptor CD44 as a marker for antigen (Ag)-
experienced, effector and memoryT cells, surprisingly little is known regarding its function
on these cells. The best-established function of CD44 is the regulation of cell adhesion
and migration. As such, the interactions of CD44, primarily with its major ligand, the extra-
cellular matrix (ECM) component hyaluronic acid (HA), can be crucial for the recruitment
and function of effector and memoryT cells into/within inﬂamed tissues. However, little is
known about the signaling events following engagement of CD44 onT cells and how coop-
erative interactions of CD44 with other surface receptors affect T cell responses. Recent
evidence suggests that the CD44 signaling pathway(s) may be shared with those of other
adhesion receptors, and that these provide contextual signals at different anatomical sites
to ensure the correct T cell effector responses. Furthermore, CD44 ligation may augment
T cell activation after Ag encounter and promote T cell survival, as well as contribute to
regulation of the contraction phase of an immune response and the maintenance of tol-
erance. Once the memory phase is established, CD44 may have a role in ensuring the
functional ﬁtness of memory T cells. Thus, the summation of potential signals after CD44
ligation on T cells highlights that migration and adhesion to the ECM can critically impact
the development and homeostasis of memoryT cells, and may differentially affect subsets
of T cells. These aspects of CD44 biology onT cells and how they might be modulated for
translational purposes are discussed.
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INTRODUCTION
CD44 is a carbohydrate-binding, type 1 transmembrane protein
that is the product of a single gene, and is represented by a family of
six isoforms that arise by mRNA splicing of 10 variably expressed
exons (Ponta et al., 2003). Further molecular heterogeneity on
various cell types is introduced by glycosylation, primarily on
the CD44 variants (English et al., 1998). CD44 is found consti-
tutively on the surface of many cell types, including resting T
cells, which exclusively express the invariant or standard form.
CD44 localizes in lipid rafts with the T cell receptor (TCR) com-
plex and is upregulated early after TCR engagement (DeGrendele
et al., 1997). Expression of CD44 variant isoforms may also be
induced, although the functional implications remain unclear
and this aspect of CD44 regulation has not been widely stud-
ied in T cells (Konig et al., 1998; Forster-Horvath et al., 2001).
Most biological and signaling functions of CD44 are associated
with binding of the primary ligand, HA, a ﬂexible copolymer
of N -acetylglucosamine and glucuronic acid that occurs natu-
rally and is an integral part of the extracellular matrix (ECM).
Whereas there have been reports that isoform usage may affect
HA binding, the N-terminal site, present in all isoforms, is suf-
ﬁcient for recognition of HA (He et al., 1992; Liao et al., 1993).
Once CD44 is upregulated on responding T cells, its expression
is sustained on effector cells as well as those cells that survive
to become memory cells after an immune response subsides. As
such, CD44 is the most widely used indicator of prior exposure
to Ag.
CD44 is best knownas a critical regulator of biological processes
involving migrating cells, including the recruitment of effector
T cells and other leukocytes to sites of infection (Ponta et al.,
2003). It has long been recognized that T cells are intrinsically
reprogrammed to migrate after their encounter with Ag (Sal-
lusto and Lanzavecchia, 2009). However, much less attention has
been devoted to the roles of adhesion receptors as vital signal-
ing molecules, which can have a profound impact not only on
differentiation of effector T cells and their responses, but also
on the development and homeostasis of memory T cells. Both
CD4+ and CD8+ memory T cells are heterogeneous with respect
to adhesion receptor expression and the potential cues they may
receive from the microenvironments in which they localize and
migrate can further inﬂuence their effector function as well as
their transition from effector to memory cells. However, both
populations of memory T cells maintain increased levels of CD44
after immune activation. Importantly, CD44 may contribute to
the functional specialization as well as the regulation of memory
in T cells through the engagement of speciﬁc signaling cascades.
Current evidence predicts that CD44 becomes repeatedly engaged
during an immune response and periodically thereafter during
the homeostatic regulation of memory T cells. Here, we discuss
the multi-functional roles of CD44 in the migration, activation,
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differentiation, and homeostasis of T cells in the context of sig-
nals received based on anatomical location, ligand availability, and
“co”-receptor interaction. The multiplicity of potential signaling
outcomes after CD44 ligation on T cells highlights that migra-
tion and adhesion to the ECM, or its components displayed on
other cells, can make critical contributions to T cell function and
homeostasis, as well as the regulation of memory.
REGULATION OF T CELL RECRUITMENT TO TISSUES BY CD44
CD44-dependent adhesion mechanisms are important for the
mobilization of effector T cells to sites of infection and inﬂamma-
tion inmany systems (Camp et al., 1993;Wittig et al., 2000; Savinov
and Strongin, 2007; discussed in more detail below). The mech-
anisms underlying lymphocyte migration into tissues have com-
mon attributes that have led to the general cascade of events that is
elicited by initial engagement, termed rolling/tethering,ﬁrm adhe-
sion, and transmigration (for review see Ley et al., 2007; Figures 1
and 2). At sites of infection, endothelial cells become activated
in response to inﬂammatory cytokines and express endothelial
selectins (E- and P-selectin) that mediate rolling (Ley and Kansas,
2004; Bonder et al., 2006). Rolling can also occur as a result
of CD44 presentation of HA on the luminal surface of vascular
endothelial cells to CD44 on the surface of effector cells (Figure 1,
left panel), which is enhanced by pro-inﬂammatory cytokines,
including IL-1 and tumor necrosis factor (TNF)-α (Jiang et al.,
2011). Chemokines presented or secreted at the endothelial cell-
surface induce signaling viaG-protein coupled receptors (GPCRs),
which results in increased integrin afﬁnity/adhesiveness (“inside-
out” signaling). Subsequently, integrin signaling itself secures
adhesion stability andmay contribute to transmigration (Ley et al.,
2007). In general, the integrins LFA-1 (αLβ2), VLA-4 (α4β1), and
α4β7 and their co-receptors ICAM-1, vascular cell adhesion mole-
cule (VCAM)-1, and mucosal addressin cell adhesion molecule-1,
respectively, regulate trafﬁcking into sites of inﬂammation. The
VLA-4-ligandVCAM-1 is induced on endothelial cells in response
to inﬂammatory cytokines and is thought to cooperate with CD44
in cell migration (Alon et al., 1995; Siegelman et al., 2000). For
example, in human mesenchymal stem cells, engagement of CD44
by HA triggered GPCR-dependent “inside-out” upregulation of
VLA-4–VCAMbinding,which enhanced adhesion and subsequent
transendothelial migration without a requirement for chemokines
(Thankamony and Sackstein, 2011). Adhesion receptors exhibit
considerable functional redundancy, which is thought to enable
the use of speciﬁc combinations for controlled entry into partic-
ular tissues. In addition, their function may be dependent on, or
augmented by,other adhesion receptors and speciﬁc combinations
of receptor expression patterns could result in a variety of poten-
tial outcomes following interaction with the endothelium during
migration.
In addition to the individual role of CD44 during migration
and its effect on the signaling outcome of other receptor–ligand
interactions, it can directly share signaling pathways with other
adhesion receptors. CD44 can associate with VLA-4 in the mem-
brane of activated T cells through its cytoplasmic tail and thereby
provide access to its signaling pathways that would have otherwise
been unavailable (Marhaba et al., 2006). For example, focal adhe-
sion kinase is associated with VLA-4, and auto-phosphorylation
creates a docking site for the Src family kinase Lck, which is asso-
ciated with CD44 (Lefebvre et al., 2010). The formation of this
complex promoted resistance of primary T cells to apoptosis via
FIGURE 1 | CD44-mediated rolling and arrest. CD44-dependent adhesion
mechanisms are important for the mobilization of effector T cells in sites of
infection and inﬂammation. At these sites, endothelial cells secrete
chemokines and express selectins (E- and P-selectin), HA, and integrin ligands
(e.g., VCAM-1) in response to inﬂammatory cytokines (left panel). CD44 can
mediate rolling interactions with vascular endothelial cells that express HA, its
natural ligand, or even E-selectin (center panel). Chemokine signaling via
GPCRs results in increased integrin afﬁnity, such as VLA-4, which enhances
adhesiveness [“inside-out” signaling (a)]. Engagement of CD44 with HA may
also trigger GPCR-dependent “inside-out” upregulation of VLA-4–VCAM
binding (b). Furthermore, CD44 may associate with VLA-4 in the membrane of
activatedT cells and augment signaling [(c) right panel]. Thus, CD44
contributes to mechanisms that allowT cells to successfully interpret
environmental signals to migrate into sites of inﬂammation.
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FIGURE 2 | CD44 is critically involved during firm adhesion and
intravascular crawling to mediate transmigration ofT cells. CD44
engagement activates the non-receptor tyrosine kinase, Pyk2, in a PI3K
dependent fashion and mediates cell spreading during ﬁrm adhesion (left
panel). In addition to Pyk2, CD44 engagement activates the Src kinase, Lck,
which is required for actin polymerization (center panel). Further, cytoskeletal
rearrangement is mediated by the ERM proteins, which are also induced
following PI3K signaling. CD44 can directly associate with the ERM proteins,
which crosslink CD44 and other proteins to the actin cytoskeleton. The
development of cell polarity and the diapedesis occurs through PECAM and
JAM that enable extrusion of ﬁlopodia into the junctions of endothelial cells
and transmigration into tissue (center and right panel). Thus, signaling via
CD44 can promote the cytoskeletal changes necessary for T cell extravasation
from the blood into tissues.
the Akt/PI3K pathway (Marhaba et al., 2006) and was crucial for T
cell recruitment in a peritonitis model (Nandi et al., 2004). CD44
can also cooperate with LFA-1 during T cell recruitment (Fan-
ning et al., 2005). Interestingly, in leukocytes, CD44 is a ligand for
E-selectin, as is P-selectin glycoprotein-1 (PSGL-1), and both mol-
ecules elicit LFA-1-dependent slow rolling via ICAM-1 by activat-
ing Src family kinases (Yago et al., 2010). Furthermore, both CD44
and PSGL-1 engage the ERM proteins ezrin, radixin, and moesin,
which regulate actin cytoskeleton rearrangement and thereby con-
vert signals from membrane proteins into cell movement. There
are many similarities between the effects of cross-linking CD44 or
LFA-1 on human T cells, both of which can elicit in vitro migra-
tion that is protein kinase C dependent (Fanning et al., 2005). It
seems therefore, that engagement of common signaling pathways
by multiple adhesion receptors provides an additional mechanism
whereby T cells may successfully interpret environmental signals
to achieve the goal of ensuring efﬁcient recruitment into sites of
inﬂammation and/or tissue damage.
Firm adhesion is typically associatedwith integrin function and
is essential for arrest and cell spreading,which are in turnnecessary
for successful transmigration from blood into tissue. CD44 con-
tributes to these processes by eliciting signaling via PI3K and Src
family kinases (Figure 2). Engagement of the PI3K signaling path-
way through CD44 also activates the non-receptor proline-rich
tyrosine kinase 2 (Pyk2) that is related to focal adhesion kinase,
which mediates signals via integrins. A recent study indicated that
Pyk2 activation was required for CD44-mediated elongated cell
spreading (Wong et al., 2011). In addition to activating Pyk2,
CD44 engagement activated Lck, which was required for actin
polymerization in T cells (Nandi et al., 2004). Furthermore, our
studies showed that ligation of CD44 elicited PI3K signaling in
Th1 cells (Baaten et al., 2010), which also induced cytoskeletal
rearrangement through the ERM proteins (Ponta et al., 2003).
CD44 directly associated with the ERM proteins (Mori et al., 2008)
and co-localization correlated with HA binding (Brown et al.,
2005). CD44 can thereby provide a direct link from the plasma
membrane to the cellular machinery and enable directed move-
ment. The ERM–CD44 complex can also regulate signaling by
Rho-ROCK family GTPases to re-organize the actin cytoskeleton.
Rho GTPases have important roles in integrin-mediated adhesion,
cell division, and cell survival, andCD44 signalingmay affect other
receptor signaling pathways via cross-talk (Tybulewicz and Hen-
derson, 2009). The development of cell polarity and diapedesis
occurs through the engagement of multiple receptors that include
platelet/endothelial adhesion molecule-1 (PECAM-1) and junc-
tional adhesion molecule A (JAM-A; Ley et al., 2007) that enable
extrusion of ﬁlopodia into the junctions of endothelial cells and
transmigration into the target tissue (Figure 3). Thus, signaling
via CD44 can promote the cytoskeletal changes necessary for T
cell recruitment from the blood into tissue and may participate
in the signaling events that affect T cell differentiation programs
and/or responses in the local microenvironment.
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FIGURE 3 |T cell motility and activation in situ is modulated by
CD44. Following diapedesis, T cells adopt an amoeboid shape and
migrate in a polarized fashion along collagen ﬁbrils in response to a
chemotactic gradient toward the site of infection/inﬂammation (left
panel). Whereas chemotactic receptors are located in the leading edge,
CD44 localizes in the uropod, which is in contact with the ECM, to
maintain a polarized shape. As movement takes place, CD44 anchorage
of the cell’s uropod to the ECM is disengaged. Migration through the
parenchymal basement membrane is facilitated by enzymatic digestions
mediated by secretion of MMPs, which may even be bound to CD44 for
directed proteolytic activity. Following efﬁcient migration to areas of
infection, T cells will encounter, recognize, and respond to antigen (right
panel). CD44 augments TCR signaling by increasing the availability of Lck
for downstream engagement of ZAP-70. CD44 ligation activates the
transcription factor, NF-κB, and induces expression of IFN-γ highlighting
its contribution to T cell activation.
A ROLE FOR CD44 IN T CELL MOTILITY WITHIN TISSUES
Little is known regarding the movement of T cells in non-
lymphoid tissues. To enter the tissue parenchyma, cells must move
through the underlying ECM, including the basement membrane,
which is primarily comprised of laminins, collagen type IV, nido-
gens, heparan sulfate, and proteoglycans (Sorokin, 2010). HA is
distributed throughout the ECM in soluble form where it con-
tributes to the scaffolds that maintain tissue integrity (Girish and
Kemparaju, 2007). In the absence of inﬂammation, the majority
of HA is found as large, high molecular weight (HMW) polymers
(>1000 kDa) that are integral to the ECM. The degradation of the
ECM into fragments, particularly of collagen and low molecular
weight (LMW) HA, is a characteristic feature of inﬂammation that
stimulates tissue remodeling, but may also modify the activity of
T cells via signaling through CD44 (see below).
T cell traversal of the endothelial basement membrane is regu-
lated by integrins that includeVLA-4 andα6β1.Migration through
the parenchymal basement membrane is mediated by secretion of
matrix metalloproteinases (MMPs), most notably the gelatinases
MMP-2 and MMP-9 whose expression is regulated by proin-
ﬂammatory cytokines (Elkington et al., 2005). CD44 has been
identiﬁed to bind MMP-9 on the cell surface of tumor cells, which
was shown tobe required for tumor invasion (Yu andStamenkovic,
1999). A similar mechanism may assist in the directed degradation
of the ECM to allow for T cell motility in the basement membrane
(Figure 3). After penetrating into the parenchyma, the cells adopt
an amoeboid shape and migrate in a polarized fashion along col-
lagen ﬁbrils in response to a chemotactic gradient toward the site
of infection/inﬂammation. To achieve directed movement within
tissues,T cells need to convertmicroenvironmental cues into intra-
cellular signals that result in the development of a polarized shape
with the formation of a lamellipodium at the leading edge of the
migrating cell and with the uropod at the rear (Figure 3). For
T cells, chemotactic receptors are located on the leading edge,
enabling them to sense chemokine gradients (del Pozo et al., 1995).
Chemotaxis results in the localization of CD44 and other adhesion
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receptors in the uropod,which is in contact with the ECM (Rosen-
man et al., 1993; del Pozo et al., 1995). As movement takes place,
CD44’s anchorage of the cell’s uropod to the ECM is disengaged by
proteolytic activity. Cleavage of the extracellular domain of CD44
is mediated by membrane type metalloproteinases on responding
T cells (Savinov et al., 2005). The development of cell polarity
depends upon remodeling of the actin cytoskeleton that is regu-
lated by the Rho family of GTPases (Tybulewicz and Henderson,
2009). Actin polymerization at the leading edge regulates for-
ward movement and the formation of the uropod. During this
process, the microtubule organizing center, Golgi apparatus, and
other organelles are redistributed to the rear of the migrating cell.
There is increasing recognition that signals transmitted during
movement can be essential for cell function. It is important to
bear in mind that the signaling pathways induced by adhesion
receptors can converge at the level of cyoskeletal rearrangement.
In vitro, cross-linking of CD44 on activated T cells by ligation with
antibody or with HA-containing ECM lattices was sufﬁcient to
induce cytoskeletal rearrangement and polarized morphology as
well as motility (Fanning et al., 2005). A recent study using intravi-
tal imaging of CD8+ T cells found impaired motility of Cd44−/−
cells within tumor explants, which could be reconstituted by rein-
troduction of full length CD44 (Mrass et al., 2008). While CD44
was not required for homing, it was needed tomaintain a polarized
shape and movement, which were essential for effective cytotoxic
activity and tumor eradication. Thus, in addition to being involved
in the recruitment of T cells to the tissue, CD44 also plays a cru-
cial role in the motility of T cells within the tissue, allowing them
to gain access to areas of inﬂammation or infection and function
appropriately.
CD44 SIGNALING IN T CELLS IN RESPONSE TO ANTIGEN
ENCOUNTER
Following efﬁcient migration to areas of infection, T cells will
encounter, recognize, and respond to Ag. During this phase, CD44
ligation could augment T cell activation, maintain polarization,
and ensure survival and further differentiation. Most of the bio-
logical responses that are mediated by CD44 are due to its binding
of HA in the N-terminal region of the molecule (Banerji et al.,
2007). Whereas the interaction between HA and CD44 is of low
afﬁnity (K d = 10–100μM), the repetitive structure of HA is such
that a single large polymer can consist of up to 10,000 disaccha-
rides and can bind to a large number of CD44 molecules (>1000;
Wolny et al., 2010). In response to inﬂammation, LMW fragments
of HA (<500 kDa, typically 8–40 mers) are generated by degrada-
tion of HMW HA by hyaluronidases. An octomer of HA appears
to represent the smallest polymer capable of mediating maxi-
mal binding to CD44 (Banerji et al., 2007). Whereas LMW HA
induces reversible CD44 binding, larger polymers seem to bind
irreversibly (Wolny et al., 2010). However, little is known regard-
ing the effects of LMW versus HMW HA binding by T cells (see
below). In general,LMWHAhas agonist functions,whereasHMW
HA has antagonist activities in a variety of cell types (Jiang et al.,
2011). The size of HA could inﬂuence the extent of CD44 aggre-
gation and association with other receptors in the cell membrane,
thereby modulating the downstream signaling pathways that are
engaged.
CD44 itself can interconvert between low and high afﬁnity HA
binding states (Ogino et al., 2010), which in T cells are inﬂuenced
by the activation status with respect to TCR signaling (Lesley et al.,
1994; Maeshima et al., 2011). Although the basis for this transition
is incompletely understood, the main mechanism involves enzy-
matic cleavage of an inhibitory terminal sialic acid residue from
N-linked sugar chains on the HA binding domain of CD44 by
an inducible sialidase (Katoh et al., 1999; Gee et al., 2003). Addi-
tional conformational changes occur upon HA binding (Takeda
et al., 2006), which may support multimerization of CD44 within
the cell membrane and thereby increase the strength of signaling.
The development of HA binding is also required for proteolytic
cleavage of extracellular and intracellular domains of CD44,which
supports feed-back regulation of CD44 synthesis (Nagano and
Saya, 2004). Although it has been reported that CD44 binds to
the ECM components ﬁbronectin and collagen in vitro, these
interactionshavenot been corroborated in vivo (Ponta et al., 2003).
CD44 is contained in detergent-insoluble lipid rafts in the cell
membrane and localizes with the TCR–CD3 signaling complex in
the immunological synapse (Hegde et al., 2008). After signaling,
the TCR–CD3 complex moves to the center of the immunologi-
cal synapse, where interactions with MHC molecules on antigen
presenting cells (APC) are facilitated. During synapse formation,
CD44, as well as CD28, LFA-1, and probablyVLA-4, relocate to the
outside edge of the complex known as the supra-molecular activa-
tion complex (Huppa and Davis, 2003). Thus, CD44 is located in
proximity to other molecules known to participate in augmenting
adhesion to APC during T cell signaling. Presentation of HA by
CD44 expressed on dendritic cells (DCs) has been shown to facil-
itate T cell–DC conjugate formation (Hegde et al., 2008), as does
LFA-1 through its interactions with ICAM-1 on APC (Fooksman
et al., 2010; Figure 4A). The ﬁnding that cross-linking CD44 acti-
vates Lck suggests an interconnection with TCR signaling (Taher
et al., 1996; Lefebvre et al., 2010). As observed with CD44 ligation,
TCR signaling also engages ERM proteins through activation of
Lck (Autero et al., 2003), which may stabilize interactions with
APC (Roumier et al., 2001). It is thought that CD44 may con-
tribute to and enhance signal transduction in the context of TCR
engagement by increasing the availability of Lck for downstream
engagement of ZAP-70,which binds to the CD3ζ chain of the TCR
and transmits the signals necessary for T cell activation. In support
of this conclusion, ligation of CD44 leads to tyrosine phosphory-
lation of Zap-70 (Taher et al., 1996). Activated Lck also contributes
to signaling by CD28 and could play a similar role in regulating
signaling by CD44 (Rozsnyay, 1999) at later stages in an immune
response.
A role for CD44 as a potential co-stimulatory molecule is sug-
gested by the ﬁnding that low doses of anti-CD3, that did not
support T cell proliferation or IL-2 induction in vitro, were ren-
dered stimulatory after antibody-mediated cross-linking of CD44
(Foger et al., 2000). Furthermore, in the context of low TCR sig-
naling, CD44 ligation induced expression of CD69 and CD25,
supporting the potential of CD44 to contribute to T cell activa-
tion. In addition, HA engagement during T cell–DC interactions
promoted the induction of IL-2 in vitro (Mummert et al., 2002).
Thus, for memory T cells that already express higher levels of
CD44, ligation could provide an immediate co-stimulatory signal
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FIGURE 4 | CD44 potentiatesT cell activation, expansion, contraction,
and maintenance of memory cells. Besides playing a pivotal role during
recruitment, CD44 ligation affects T cell memory function by augmenting
activation (A), ensuring survival (B), and regulating homeostasis (C) to
facilitate maximum expansion following challenge (D). Following recognition
of Ag via TCR, CD44 afﬁnity and expression are upregulated and it localizes
with theTCR signaling complex in the immunological synapse where it
receives signals from HA presented by CD44 expressed on DCs (panel 1).
CD44 ligation contributes to and enhances signal transduction in the context
of TCR engagement by increasing the availability of Lck for downstream
engagement of ZAP-70, which transmits the signals necessary for T cell
activation. Signaling events in the primary response to infections can
profoundly affect the generation and maintenance of T cell memory (panel 2).
HA binding to CD44 can induce a survival signal via the PI3K/Akt pathway,
which may inhibit apoptosis during contraction by interfering with cell death
either through direct obstruction of Fas to prevent DISC assembly and
caspase 8 activation or by affecting Fas signaling itself. Although differences
in the capacity of LMW versus HMW HA to elicit CD44-mediated signaling in
T cells has not been carefully investigated, recent studies suggest that HMW
(red bar), but not LMW (green bar), HA (A–D) can upregulate the transcription
factor FoxP3 in Tregs cells via CD44 signaling (panel 3). CD44-regulated FoxP3
expression was linked to a greater capacity for IL-10 production and the
development of surfaceTGF-β1 expression, which are important for their
regulatory function.We hypothesize that effector T cells are more likely to
respond to LMW HA generated during inﬂammation. Furthermore, during
homeostasis, we envision that HA binding by CD44 elicits enhanced survival
due to engagement of Lck (panel 4). CD44 signaling may increase the
responsiveness of IL-7Rα by making more Lck available leading to
IL-7-mediated upregulation of Bcl-2 via Stat5 signaling. Thus, CD44 could have
a global function in regulating the transition of effector cells to memory cells,
as well as in maintaining memoryT cells that exceeds its roles in migration
and motility.
leading to more rapid T cell activation compared to naïve T cells.
One caveat for the studies of CD44 signaling in T cells is that most
work has focused on cell lines and in vitro analyses with mono-
clonal antibodies. Signals transmitted by cross-linking CD44 with
various monoclonal antibodies are likely to differ since they can
have widely disparate effects on the induction of HA binding,
as well as CD44 external domain shedding (Zheng et al., 1995).
Efforts to recapitulate CD44 interactions with HA and/or ECM
lattices in vitro may also not faithfully reveal the signaling path-
ways that are engaged physiologically. Nevertheless, it is likely that
in the context of HA binding, CD44 can augment TCR signaling
and impact the T cell response in a context-dependent manner.
With the perspective of the potential outcomes of CD44 signaling
described above, HA availability on DCs and other APCs in sites
of inﬂammation is likely to be a signiﬁcant factor. The extent of
co-stimulation can greatly impact the differentiation of Th sub-
sets and is essential for the development of memory. It is notable
that CD4+ T cells from Cd44−/− mice appear to be defective
in Th1 cell responses. They exhibit enhanced expression of the
Th2 transcription factor GATA3 and diminished expression of the
Th1 transcription factor T-bet after in vivo immunization (Guan
et al., 2009). Furthermore, naive CD4+ T cells from Cd44−/−
mice more readily differentiate into Th2 than Th1 cells in vitro,
which is seemingly regulated on an epigenetic level (Guan et al.,
2011). Consistent with these ﬁndings, our studies indicated that
CD44 regulates the survival of Th1 cells, but not Th2 cells, which
could account for Th2 bias in Cd44−/− mice (Baaten et al., 2010).
At sites of inﬂammation, tissue damage causes the accumula-
tion of LMW HA fragments and the release of multiple proinﬂam-
matory mediators from DCs and macrophages, including IL-12,
Frontiers in Immunology | Immunological Memory February 2012 | Volume 3 | Article 23 | 6
Baaten et al. T cell memory and CD44
TNF-α, and several chemokines (Konig et al., 1998). Whether T
cells can be induced to produce cytokines in response to LMW
HA binding in vivo is unknown, but in vitro induction of inter-
feron (IFN)-γ has been observed (Blass et al., 2001). A recent study
using the murine multiple sclerosis model experimental autoim-
mune encephalitis (EAE), demonstrated that Cd44−/− mice had
greatly reduced severity of disease with fewer CD4+ T cells in
CNS inﬁltrates, which produced lower levels of IFN-γ and IL-17
compared to cells from WT mice (Guan et al., 2011), suggesting
a potential role for CD44 in either regulating the development of
effector T cells or their production of cytokines. Another mech-
anism that could account for regulation of activated T cells by
CD44 is through the cytokine, osteopontin (OPN),which is widely
produced in sites of inﬂammation and binds to v7-containing iso-
forms of CD44. OPN upregulated T-bet in CD4+ T cells and
enhanced Th1 cell differentiation in vitro (Shinohara et al., 2005).
Furthermore, OPN has been previously shown to promote the
survival of activated T cells in EAE in part by inhibiting the
transcription factor Foxo3a and activating the transcription fac-
tor NF-κB (Hur et al., 2007), as well as modulating the levels
of proapoptotic Bcl-2 family members. Whether this occurs in
response to direct-binding of CD44 by OPN was not addressed,
but both could occur via modulation of Akt signaling (Lin and
Yang-Yen, 2001).
Although differences in the capacity of LMW versus HMW HA
to elicit CD44-mediated signaling in T cells has not been care-
fully investigated, recent studies suggest that there are likely to be
important distinctions. Interestingly, CD44–HA interactions have
been demonstrated to control the activity of naturally occurring
FoxP3+, CD25+ regulatory T cells (Tregs). HMW, but not LMW,
HA can upregulate the transcription factor FoxP3 in Tregs cells via
CD44 signaling (Figure 4). The development of FoxP3 expression
was associated with the induction of regulatory function (Bollyky
et al., 2007). Surprisingly,CD44 regulated FoxP3 expression in part
by inducing IL-2 production, which was linked to a greater capac-
ity for IL-10 production and the development of surface TGF-β1
expression (Bollyky et al., 2009). Consistent with these ﬁndings,
Tregs fromCd44−/−mice exhibited impaired regulatory function.
Expression levels of CD44 were upregulated on Tregs after activa-
tion in vitro, and a signiﬁcant proportion bound exogenous HA,
which was linked to a greater capacity to inhibit allogeneic and
graft versus host responses in vivo (Firan et al., 2006). Together,
these results reveal that T cells can engage HMW HA and suggest
that CD44–HA binding could have an unexpected role in the con-
traction of immune responses, in the resolution of inﬂammation,
and inmaintaining tolerance to self-Ags. Although not yet studied,
presumably effector T cells that become activated in the context of
an immune response and inﬂammation will have the opportunity
to bind LMW HA.
POTENTIAL ROLES OF CD44 IN THE REGULATION OF T CELL
MEMORY
Signaling events in the primary response to infections can pro-
foundly affect the generation and maintenance of T cell memory.
Our recent study demonstrated a previously unexpected role for
signaling via CD44 during a primary response to inﬂuenza virus
infection in the survival and generation of memory in Th1 cells,
but not Th2 or Th17 cells (Baaten et al., 2010). Thus, as with CD28
and OX40, signaling via CD44 could contribute to maintaining
effector responses through engagement of survival mechanisms,
particularly in Th1 cells, and thereby contribute to the develop-
ment of memory. However, ligation of CD28 (Boise et al., 1995)
or OX40 (Rogers et al., 2001) induced an increase in the anti-
apoptotic Bcl-2 family member Bcl-xL that was not observed with
CD44. Instead, we showed that CD44 can signal via the PI3K/Akt
pathway selectively in Th1 cells (Baaten et al., 2010), a mechanism
by which HA binding to CD44 promotes survival and growth of
some tumor cells (Bourguignon et al., 2008; Figure 4). This path-
way can also be engaged by CD28 in CD4+ T cells, and inhibit
apoptosis by interfering with Fas-mediated cell death by prevent-
ing assembly of the death-inducing signaling complex (DISC) that
is necessary to activate caspase 8 (Jones et al., 2002). Indeed, other
studies in cancer cells showed that CD44 may directly interfere
with Fas to prevent DISC assembly and thereby control resistance
versus susceptibility to Fas-mediated cell death (Hauptschein et al.,
2005) via interaction with the ECM (Lee et al., 2008). Although
studies of Jurkat T cells,which lackCD44, showed that transfection
with CD44 variant isoforms, rather than the standard form, could
inhibit Fas-mediated apoptosis (Mielgo et al., 2006), we could not
discern any differences in CD44 variant usage between primary
Th1 andTh2 cells (Baaten et al., 2010).Nevertheless,Th1 cells have
been previously demonstrated to be more susceptible to apopto-
sis than Th2 cells (Varadhachary et al., 1997; Zhang et al., 1997)
and we showed that Th1 cells express higher levels of Fas than do
Th2 or Th17 cells, irrespective of the presence of CD44 (Baaten
et al., 2010). Thus, control of survival in Th1 cells may be more
dependent on regulation by CD44 because of higher expression
of Fas, and lower inherent expression of Akt/PI3K (Varadhachary
et al., 1999). Alternatively, CD44 signaling might have an indirect
effect on T cell survival. Given its role in trafﬁcking, CD44 may
affect T cell localization to a niche where memory T cells receive
survival signals via other mechanisms. However, in our hands, T
cell localization was not dramatically affected in the absence of
CD44 (Baaten et al., 2010). Nevertheless, the deleterious effects of
Cd44 deﬁciency on memory CD4 T cell survival highlight the vital
role CD44 plays in memory T cell development.
Although the molecular basis of the regulated changes in cen-
tral trafﬁcking molecules during effector T cell development is
beginning to be understood, much less is known regarding how
changes in adhesion receptor expression impact memory T cells.
There has been considerable effort devoted to investigating the
functional regulation of memory T cells by compartmentalizing
them on the basis of their trafﬁcking molecules (Sallusto et al.,
2004). Central memory cells (TCM) remain in the lymphoid com-
partment and express the lymph node homing receptor, CD62L,
and/or the chemokine receptor, CCR7. More differentiated effec-
tor memory cells (TEM) lack these molecules and more readily
localize in non-lymphoid tissues in addition to being found in the
circulation. The sustained high level of CD44 expression on all
Ag-experienced T cells suggests that this molecule has the poten-
tial to regulate memory T cells during migration, adhesion, and
motility as detailed above. Whereas both CD4+ and CD8+ T cells
can undergo initial activation and expansion in the absence of
CD44 (Mrass et al., 2008; Baaten et al., 2010), it is possible that
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CD44 is not generally needed for T cell priming when Ag levels
are high and TCR signaling is strong during the initial phases of
the immune response. Because CD44 signals can enhance T cell
responses when TCR signals are low (Foger et al., 2000), they may
contribute to the formation of memory as Ag levels diminish dur-
ing the course of an immune response. The paucity of Ag also
favors the generation of CD62L+ TCM cells that are less differ-
entiated than TEM cells, which retain the capacity for immediate
effector function (Catron et al., 2006). We have demonstrated that
Cd44-deﬁcient Th1 cells that are withdrawn from overt TCR stim-
ulation fail to survive as memory cells over time when transferred
into naïve recipients (Baaten et al., 2010). We did not ﬁnd dif-
ferences in CD44 expression on CD4+ effector T cells that were
sorted on the basis of CD62L expression to distinguish precursors
of TCM and TEM memory cells. Moreover, in the absence of CD44
expression, both subsets were equally susceptible to decay in vivo
in the absence of overt stimulation by Ag. These results imply that,
at least for CD4+ T cells, CD44 could play a role in the survival of
those effectors cells that persist through the contraction phase to
become memory cells.
In addition to the roles in effector and memory generation,
CD44 may also contribute to memory T cell homeostasis. A recent
study shows that a subset of memory CD8+ T cells expresses
CD44-mediated HA binding (Maeshima et al., 2011). These T
cells are enriched in TCM phenotype memory cells, and exhibit
an enhanced capacity to proliferate in response to the common
γ-chain cytokines IL-7 and IL-15, which are required for the
maintenance of memory T cells. In some models of infection,
memory CD8+ T cell precursors have been subdivided based on
the expression of two surface markers, IL-7 receptor α (IL-7Rα)
and killer cell lectin-like receptor subfamily G,member 1 (KLRG1;
Kaech et al., 2003; Joshi et al., 2007). Whereas short-lived effector
cells are characterized by low IL-7Rα and high KLRG1 expression,
memory precursor effector cells (MPECs) are characterized by
high IL-7Rα and low KLRG1 expression. It is not known whether
levels of cell-surface CD44 differ among these T cell subsets or
whether they might be differentially regulated by CD44-mediated
signaling. Previous studies indicate that Lck associates with the
IL-7Rα and is activated in response to IL-7 engagement, which
itself is dependent on the activation status of the T cell (Page et al.,
1995, 1997). We hypothesize that HA binding by CD44 elicits a
greater homeostatic response to IL-7 by increasing the availabil-
ity of Lck (Figure 4). Thus, increased responsiveness of IL-7Rα
to IL-7 in response to HA binding could promote enhanced sur-
vival in response to IL-7-mediated upregulation of Bcl-2, a key
target of IL-7R signaling. Since HA binding by CD44 is upreg-
ulated in response to TCR signaling, it is possible that memory
cells expressing this activity represent the population undergoing
homeostatic turnover drivenbypeptide-MHCrecognitiononDCs
that express surface HA (Boyman et al., 2009), which contributes
to the maintenance of memory T cell function (Kassiotis et al.,
2002). In this scenario, we envision that HA binding is acquired
transiently with periodic cycles of TCR engagement. However, it is
possible that the frequency of HA-binding T cells has been under-
estimated in the contexts in which it has been studied, particularly
since it is often detected only by the ability to take up exogenous
HA,whichdoes not take into account thatHA is potentially already
bound and can be detected on the surface withHAbinding protein
(Cichy et al., 2002). Furthermore, the cycling between HA bind-
ing and non-binding states of CD44 may permit engagement and
disengagement of memory cells from HA during migration and
interaction with DCs. Thus, consistent with the sustained expres-
sion of CD44 on memory T cells, emerging evidence suggests that,
beyond roles in migration and motility, CD44 could have a global
function in possibly regulating the transition of effector cells to
memory cells, as well as in maintaining memory T cells. There-
fore, on T cells, engagement of CD44 could impact the outcome of
memory responses at multiple points after an initial Ag encounter.
CD44 AND ITS IMPORTANCE FOR OPTIMAL T CELL
IMMUNITY DURING INFECTION
CD44 has been shown to be important in mediating innate
immune cell function (Matsumoto et al., 1998; Larkin et al., 2006;
Shirali and Goldstein, 2008) and innate immunity following bac-
terial infections. For example, lung infection with Mycobacterium
tuberculosis in Cd44-deﬁcient mice led to increased neutrophil
inﬁltration with no differences in leukocyte entry or bacterial
clearance (Kipnis et al., 2003). In addition, pulmonary infection
with Escherichia coli promoted increased neutrophil inﬁltration
and inﬂammation in the lung, which was not observed when mice
were infected with Streptococcus (Wang et al., 2002). However, lit-
tle progress has been made in examining the function of CD44
on T cells in response to infection with microbial pathogens. We
recently showed a critical function for CD44 in optimal Th1 cell
memory development against inﬂuenza virus infection (Baaten
et al., 2010). It is possible that inappropriate CD4+ T cell help
during the immune response against pathogens could impact opti-
mal development of effector and/or memory CD8+ T cells after
inﬂuenza virus infection, as has been shown in other acute (Bour-
geois et al., 2002; Janssen et al., 2003; Shedlock and Shen, 2003;
Sun and Bevan, 2003) and chronic infections (Matloubian et al.,
1994). Indeed, in the absence of CD4+ T cell help, maintenance
and recall of CD8+ memory to inﬂuenza virus challenge is com-
promised and the clearance of residual virus delayed (Belz et al.,
2002; Johansen et al., 2004). Additionally, in the absence of Th1
cells, B cell responses and the generation of long-lived plasma
cells may be compromised. Profound immune defects from the
absence of Th1 cells can result in enhanced pathogen spread or
delayed pathogen clearance following infection.
In another study, the intrinsic effect of CD44 on T cell expan-
sion following acute lymphocytic choriomeningitis virus infection
was examined, and despite ﬁnding similar numbers of IFN-γ-
producing CD4+ T cells, virus-speciﬁc CD8+ T cell expansion
was decreased in the Cd44-deﬁcient compartment (Graham et al.,
2007). Antibody blockade of CD44 in mice infected with Toxo-
plasma gondii resulted in a lack of IFN-γ production by CD4+ T
cells, which protected treated mice from exuberant inﬂammation
(Blass et al., 2001). Interestingly, IFN-γ production in CD4+ T
cells was restored upon addition of LMW HA to T cell cultures.
Together, these ﬁndings indicate that CD44-mediated signals are
important in T cell function and survival and are necessary for
both CD4+ and CD8+ T cell responses after infection. However,
more studies are necessary to investigate the role of CD44 during
infections, as the few that have been done highlight the complexity
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of CD44 function. It may play speciﬁc contrasting roles on differ-
ent cell types and the outcome for the host may depend on the
pathogen encountered. It will be important to determine whether
there are extrinsic roles for CD44, e.g. on APCs or Tregs, which
can impact and/or inﬂuence an ongoing T cell response during
infection. Along with TCR–MHC and co-stimulatory signals, the
contextual signals through CD44 and its ligand may also impact
effector and/or memory T cell fates after microbial infections.
TARGETING CD44 ON T CELLS TO AMELIORATE DISEASE: THE
EXAMPLE OF TYPE 1 DIABETES
CD44 has long been considered to have important potential as
a therapeutic target to control inﬂammation. Early studies on
the effects of blocking CD44 showed that skin contact sensitivity
responses were diminished because of reduced lymphocyte and
leukocyte inﬁltration (Camp et al., 1993), a result also seen in
atopic dermatitis in Cd44-deﬁcient mice (Gonda et al., 2005). In
addition,pulmonary injury and allergic responseswere reduced by
anti-CD44 antibody treatment (Katoh et al., 2003; Li et al., 2011).
In contrast, Cd44-deﬁcient animals cannot control acute induced
pulmonary inﬂammation due to the inability to clear soluble
HA (Teder et al., 2002). Likewise, in different models of hepatic
inﬂammation, targeting CD44 can have protective (McDonald
et al., 2008) or deleterious effects (Chen et al., 2001). Despite
the potential for such diverse outcomes, consistent therapeutic
effects are observed after interfering with CD44 function in mod-
els of chronic inﬂammation, particularly autoimmune diseases.
These include induced models of arthritis, multiple sclerosis, col-
itis, and type 1 diabetes (T1D; reviewed in Johnson and Ruffell,
2009). Overall, these studies reveal that amelioration of disease
is due to reduced inﬂammatory inﬁltrates in the target tissues.
However, studies of T1D suggested that control of inﬂamma-
tion can be achieved by altering the migration and survival of
effector/memory T cells and Tregs in addition to migration as
summarized below.
Type 1 diabetes represents an important example of a chronic
disease that can be prevented by treatment with anti-CD44 during
theprediabetic phase in theNODmousemodel (Weiss et al., 2000).
Although the development of this disease is multifactorial, T cells
orchestrate the inﬂammation that leads to destruction of insulin-
producing islet β-cells. Blocking CD44 activation by enzymatic
cleavage abolished the migration of islet-Ag-speciﬁc CD8+ T cells
into the pancreas and prevented development of diabetes (Savinov
and Strongin, 2007). We observe that anti-CD44 treatment pre-
vents diabetogenic CD4+ and CD8+ T cells from accumulating in
the pancreas (unpublished observations). Many additional studies
aswell as our ownhave provided evidence that blockingHA–CD44
binding can promote the death of activated T cells (Ruffell and
Johnson, 2008; Baaten et al., 2010), which is associated with the
amelioration of inﬂammation in a colitis model (Wittig et al.,
1998). Thus, the development and survival of memory in Th1
CD4+ T cells may also be controlled by targeting CD44 in T1D.
Importantly, the activity of regulatory T cells can be augmented
after CD44 ligation due to a direct effect on their inhibitory func-
tion (Bollyky et al., 2009), revealing an unexpected role of CD44
in the maintenance of tolerance. Together, these ﬁndings suggest
that the combined effect of modulating CD44-signaling on T cells
could control the inﬂammatory response in T1D through multiple
mechanisms.
Another area of investigation where anti-CD44 treatment may
provide a beneﬁt for T1D is in islet-transplantation to restore
insulin production after diabetes onset. A recent study in a non-
autoimmune model demonstrated that administration of anti-
CD44 prolonged survival of allogeneic islets after transplantation
(Peng et al., 2011). This improvement was associated with greatly
reduced accumulation of CD4+ T cells within the grafts and
diminished levels of IFN-γ in the sera of treatedmice. These results
support the concept that CD44 on T cells represents an important
target for the treatment of T1D in particular, but possibly other
T cell-dependent autoimmune diseases as well. However, before
the clinical translation of biologics or small molecules that target
CD44 can be considered, a better understanding of the conse-
quences are needed in light of CD44’s multiple distinct roles in
several cell types.
CONCLUSION
Modulation of signaling via adhesion receptors can contribute
to multiple, often overlooked aspects of T cell regulation. While
increased expressionof several adhesion receptors on activated and
memory T cells signiﬁes greater migratory capacity, the example
of CD44 demonstrates the underappreciated roles that a single
constitutively expressed adhesion receptor can play in integrat-
ing signals within the microenvironment, which can impact T cell
activation, proliferation, differentiation, survival, locomotion, and
function. By these processes, CD44 can inﬂuence not only the fates
of responding T cells, but also the generation and maintenance of
memory and control of autoimmunity.
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